RTI Surgical Spikes After Dodging FDA Warning
Published: Sep 16, 2013
RTI Surgical gets some Wall Street love on announcing that a new FDA inspection confirms changes made at its Florida manufacturing facility. Florida-based RTI Surgical (NSDQ:RTIX) announced this week that a new inspection of its manufacturing facility confirmed that the company had taken the appropriate actions to correct issues cited in an FDA warning letter issued last year. The announcement sent RTIX shares up 12% by around 4 p.m. after the announcement on Wednesday, September 11, when they were trading at $3.93, up from an open price of $3.56.
Help employers find you! Check out all the jobs and post your resume.